Clinical Trial Update: QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for QH101 Cell Therapy in relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• QH101 Cell Therapy

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: MDS, AML | Phase 1 | Status: NOT_YET_RECRUITING